Strategic Shifts & Business Growth

RGP appoints Daniel Boyer to a new Head of M&A role, signaling a strategic push to merge finance and tech expertise for today's complex transactions.

The iconic watchmaker and legendary fashion designer unite for a new collection, blending sustainable tech with high fashion to capture a booming market.

In a tough PE climate, Truelink Capital rapidly closes its second fund at its $2B hard cap, signaling strong investor belief in its operational strategy.

DevRev expands its AI platform in India, aiming to move enterprise AI from pilot to production and solve the 'clarity crisis' with new agent tools.

A new, highly selective drug for Duchenne muscular dystrophy shows potential to be safer and more effective, targeting both muscle and heart decline.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

Backed by Chicago Ventures, ILS aims to eliminate tedious manual tasks for investment lawyers with its fast-growing AI-powered side letter platform.

Kettering University’s century-old co-op model is topping elite schools in job outcomes, offering a debt-reducing blueprint for higher education's future.

Canadians lost over $704 million to scams in 2025, but that's just the tip of the iceberg. A new multi-agency campaign tackles the hidden crisis.

The global firm secured over $18M in contracts for LA's Convention Center modernization and key stormwater programs, shaping the city's economic and eco-future.

Americold holds its quarterly dividend steady at $0.23/share, signaling stability to investors while navigating industry headwinds with a new strategic plan.

AFM Capital's majority stake in Incodema3D signals a major bet on advanced manufacturing for the defense, aerospace, and space industries.

With a 30-year operations veteran retiring, Delta promotes a new president, COO, and CFO, betting on internal talent to navigate its future growth.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

With $15M from top UAE families, TruDoc is scaling its 'hospital-at-home' model, signaling a major shift in how the GCC delivers critical care.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

Backed by Shift4 and Castle Island, Cyclops aims to simplify stablecoin adoption for payment firms with a new, all-in-one platform.

Top tech vendors showcase AI-driven tools at the Business Architecture Innovation Summit, aiming to solve the high failure rate of corporate transformations.

The biotech plans to separate its R&D pipeline from its booming royalty assets, creating two public companies and winning applause from Wall Street.

As data centers face an energy crisis, a new exec hire at TRIMAX signals a strategic push into the lucrative secondary power market.